PT - JOURNAL ARTICLE AU - Jia-wei Zhong AU - Yu-jia Jin AU - Zai-jun Song AU - Bo Lin AU - Xiao-hui Lu AU - Fang Chen AU - Lu-sha Tong TI - Deep learning for automatically predicting early haematoma expansion in Chinese patients AID - 10.1136/svn-2020-000647 DP - 2021 Feb 01 TA - Stroke and Vascular Neurology PG - svn-2020-000647 4099 - http://svn.bmj.com/content/early/2021/03/24/svn-2020-000647.short 4100 - http://svn.bmj.com/content/early/2021/03/24/svn-2020-000647.full AB - Background and purpose Early haematoma expansion is determinative in predicting outcome of intracerebral haemorrhage (ICH) patients. The aims of this study are to develop a novel prediction model for haematoma expansion by applying deep learning model and validate its prediction accuracy.Methods Data of this study were obtained from a prospectively enrolled cohort of patients with primary supratentorial ICH from our centre. We developed a deep learning model to predict haematoma expansion and compared its performance with conventional non-contrast CT (NCCT) markers. To evaluate the predictability of this model, it was also compared with a logistic regression model based on haematoma volume or the BAT score.Results A total of 266 patients were finally included for analysis, and 74 (27.8%) of them experienced early haematoma expansion. The deep learning model exhibited highest C statistic as 0.80, compared with 0.64, 0.65, 0.51, 0.58 and 0.55 for hypodensities, black hole sign, blend sign, fluid level and irregular shape, respectively. While the C statistics for swirl sign (0.70; p=0.211) and heterogenous density (0.70; p=0.141) were not significantly higher than that of the deep learning model. Moreover, the predictive value for the deep learning model was significantly superior to that of the logistic model of haematoma volume (0.62; p=0.042) and the BAT score (0.65; p=0.042).Conclusions Compared with the conventional NCCT markers and BAT predictive model, the deep learning algorithm showed superiority for predicting early haematoma expansion in ICH patients.